Tim O’Brien

Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial)

Tim O’Brien, Eleanor Ray, Rajinder Singh et al. · European Urology · 2011 · 339 citations

Urological Research, Urology, Surgical Oncology +7

Different angiogenic pathways characterize superficial and invasive bladder cancer.

Tim O’Brien, David Cranston, S Fuggle et al. · PubMed · 1995 · 293 citations

Urology, Angiogenesis, Tumoral Pathology +14

Regulation of E-cadherin Expression by <i>VHL</i> and Hypoxia-Inducible Factor

Miguel A. Esteban, Maxine Tran, Sarah K. Harten et al. · Cancer Research · 2006 · 257 citations · Full text

Vascular Endothelial Growth Factor is a Predictor of Relapse and Stage Progression in Superficial Bladder Cancer

Jeremy Crew, Tim O’Brien, Mike Bradburn et al. · The Journal of Urology · 1998 · 226 citations

Vegf Protein, Tumor Biology, Urology +13

The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.

Tim O’Brien, David Cranston, S Fuggle et al. · PubMed · 1996 · 167 citations

Urology, Tumoral Pathology, Poor Outcome +15